Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
Monster Beverage
MNST
|
+$584M |
| 3 |
Intercontinental Exchange
ICE
|
+$534M |
| 4 |
Applied Materials
AMAT
|
+$386M |
| 5 |
Johnson & Johnson
JNJ
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.95B |
| 2 |
Texas Instruments
TXN
|
+$750M |
| 3 |
Deere & Co
DE
|
+$539M |
| 4 |
Microsoft
MSFT
|
+$507M |
| 5 |
Meta Platforms (Facebook)
META
|
+$488M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.99% |
| 2 | Healthcare | 19.86% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.49% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Edgewise Therapeutics
EWTX
$4.31B
| $122M | 0.06% |
4,558,519
+1,951,220
| +75% | +$38.8M |
|
252
Carlisle Companies
CSL
$13.1B
| $120M | 0.06% |
266,296
-68,114
| -20% | -$28.2M |
|
253
RTX Corp
RTX
$291B
| $118M | 0.06% |
976,527
+702,699
| +257% | +$80.1M |
|
254
Tesla
TSLA
$1.2T
| $116M | 0.06% |
444,091
+19,342
| +5% | +$4.41M |
|
255
Trip.com Group
TCOM
$29.2B
| $115M | 0.06% |
1,940,993
-16,927
| -0.9% | -$783K |
|
256
Alibaba
BABA
$276B
| $115M | 0.06% |
1,081,188
+490,694
| +83% | +$40.1M |
|
257
Janux Therapeutics
JANX
$899M
| $115M | 0.06% |
2,523,406
+721,563
| +40% | +$31.4M |
|
258
Gates Industrial Corporation Ltd.
GTES
$6.36B
| $114M | 0.06% |
6,484,706
+7,670
| +0.1% | +$131K |
|
259
UL Solutions
ULS
$18.3B
| $114M | 0.06% |
2,307,651
-20,559
| -0.9% | -$1M |
|
260
STAG Industrial
STAG
$7.47B
| $113M | 0.06% |
2,900,765
-562,849
| -16% | -$22.1M |
|
261
Telus
TU
$17.1B
| $113M | 0.06% |
6,701,819
+49,088
| +0.7% | +$793K |
|
|
ETNB
262
DELISTED
89bio
ETNB
| $112M | 0.06% |
15,158,218
+1,882,108
| +14% | +$15.8M |
|
263
Nice
NICE
$6.13B
| $112M | 0.06% |
644,447
-479,448
| -43% | -$82.3M |
|
264
SPX Corp
SPXC
$9.6B
| $111M | 0.06% |
696,713
+217,316
| +45% | +$32.8M |
|
265
Insmed
INSM
$22.6B
| $109M | 0.06% |
1,488,904
-602,874
| -29% | -$44.5M |
|
266
Maximus
MMS
$3.32B
| $108M | 0.06% |
1,163,439
+1,000
| +0.1% | +$89.4K |
|
|
SUM
267
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $108M | 0.06% |
2,771,481
+2,175
| +0.1% | +$83.6K |
|
268
BellRing Brands
BRBR
$1.54B
| $108M | 0.06% |
1,775,559
+6,951
| +0.4% | +$386K |
|
269
Doximity
DOCS
$3.92B
| $107M | 0.06% |
2,464,887
-13,662
| -0.6% | -$456K |
|
270
Occidental Petroleum
OXY
$55.7B
| $107M | 0.05% |
2,079,827
-224,967
| -10% | -$12.8M |
|
271
Legend Biotech
LEGN
$3.64B
| $107M | 0.05% |
2,185,634
-173,422
| -7% | -$9.24M |
|
|
NVO
272
Novo Nordisk
NVO
$228B
| $106M | 0.05% |
892,427
-1,170
| -0.1% | -$156K |
|
273
Inspire Medical Systems
INSP
$1.5B
| $106M | 0.05% |
502,609
+27,374
| +6% | +$4.76M |
|
274
Regeneron Pharmaceuticals
REGN
$73.1B
| $103M | 0.05% |
98,134
-2,290
| -2% | -$2.55M |
|
275
Booz Allen Hamilton
BAH
$8.63B
| $103M | 0.05% |
631,703
+146,420
| +30% | +$22.4M |
|
Similar funds
Janus Henderson Group's Q3 2024 Portfolio in Review
As of Q3 2024, Janus Henderson Group held 2,584 positions worth $195B, up 4.6% from $187B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.7%. Janus Henderson Group opened 66 new positions and exited 56, leaving the 2,584-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2024 buy was Janus Henderson Emerging Markets Debt Hard Currency ETF: 4,369,165 shares worth $228M.
- Janus Henderson Group added most to Broadcom in Q3 2024, an estimated $605M increase.
- Janus Henderson Group's biggest Q3 2024 reduction was Texas Instruments, cutting an estimated $750M.
- Janus Henderson Group fully exited Lam Research in Q3 2024, selling an estimated $1.95B.
- Janus Henderson Group's ten largest holdings make up 30% of its $195B portfolio in Q3 2024.
- Janus Henderson Group opened 66 new positions and closed 56 in Q3 2024.
- Janus Henderson Group's portfolio value rose 4.6% quarter-over-quarter to $195B.
Based on Janus Henderson Group's 13F filing for Q3 2024, filed 14 Nov 2024.